Your browser doesn't support javascript.
loading
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia.
Johansson, Patricia; Klein-Hitpass, Ludger; Choidas, Axel; Habenberger, Peter; Mahboubi, Bijan; Kim, Baek; Bergmann, Anke; Scholtysik, René; Brauser, Martina; Lollies, Anna; Siebert, Reiner; Zenz, Thorsten; Dührsen, Ulrich; Küppers, Ralf; Dürig, Jan.
Afiliación
  • Johansson P; Department of Hematology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. patricia.johansson@uk-essen.de.
  • Klein-Hitpass L; Institute of Cell Biology (Cancer Research), University Hospital Essen, University of Duisburg-Essen, Essen, Germany. patricia.johansson@uk-essen.de.
  • Choidas A; Institute of Cell Biology (Cancer Research), University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Habenberger P; Lead Discovery Center GmbH, Dortmund, Germany.
  • Mahboubi B; Lead Discovery Center GmbH, Dortmund, Germany.
  • Kim B; Center for Drug Discovery, Department of Pediatrics, Emory Center for AIDS Research, Emory University, Children's Healthcare of Atlanta, Atlanta, GA, USA.
  • Bergmann A; Center for Drug Discovery, Department of Pediatrics, Emory Center for AIDS Research, Emory University, Children's Healthcare of Atlanta, Atlanta, GA, USA.
  • Scholtysik R; Institute for Human Genetics, Christian-Albrechts-University Kiel and University Hospital Schleswig Holstein, Kiel, Germany.
  • Brauser M; Institute of Cell Biology (Cancer Research), University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Lollies A; Institute of Cell Biology (Cancer Research), University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Siebert R; Institute of Cell Biology (Cancer Research), University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Zenz T; Institute for Human Genetics, Christian-Albrechts-University Kiel and University Hospital Schleswig Holstein, Kiel, Germany.
  • Dührsen U; Institute of Human Genetics, University of Ulm and University Hospital of Ulm, Ulm, Germany.
  • Küppers R; Department of Molecular Therapy in Haematology and Oncology, National Center for Tumor Diseases and German Cancer Research Center, Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany.
  • Dürig J; German Cancer Consortium (DKTK), Heidelberg, Germany.
Blood Cancer J ; 8(1): 11, 2018 01 19.
Article en En | MEDLINE | ID: mdl-29352181
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Prolinfocítica de Células T / Transducción de Señal / Proteína 1 que Contiene Dominios SAM y HD / Mutación Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Prolinfocítica de Células T / Transducción de Señal / Proteína 1 que Contiene Dominios SAM y HD / Mutación Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2018 Tipo del documento: Article